Drugdiscoverynews.com
Visit drugdiscoverynews.com-
324.4K
Global Rank
-
534
Daily Visitors
-
3 days ago
Last scanned
-
19 years
Domain Age
Drugdiscoverynews.com
Visit drugdiscoverynews.com
About Website
Updated:
Drug Discovery News, Development & Diagnostics Articles | DDN Magazine
Drug Discovery News Website
Network Data
This website is hosted with LabX Media Group, which reserves the following IP addresses for drugdiscoverynews.com: 216.223.155.118. Moreover, DNS used with this website include ns11.constellix.com, ns21.constellix.com, ns31.constellix.com, ns41.constellix.net, ns51.constellix.net, ns61.constellix.net. Subnet identifier ranges from 216.223.155.112 to 216.223.155.127. Classless Inter-Domain Routing (CIDR) is 216.223.155.112/28. ARIN net type is Reassigned.
-
324.4K
Global Rank
-
534
Daily Visitors
-
3 days ago
Last scanned
-
19 years
Domain Age
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ns11.constellix.com
ns21.constellix.com
ns31.constellix.com
ns41.constellix.net
ns51.constellix.net
ns61.constellix.net
Whois
OWNERSHIP
-
Created
2004-09-22
-
Expires
2024-09-22
-
Owner
Registration Private (Domains By Proxy, LLC)
-
Registar
GODADDY.COM, LLC
-
Owner Emails
Domain & Keywords
The registrar of drugdiscoverynews.com is GODADDY.COM, LLC and the name expires on 2024-09-22. According to open source data, you can reach the owner at ljdoyle@comcast.net but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
- discovery
- drug discovery
- development
- biotech
- life sciences
- drug development
- pharmaceutical development
- modern drug discovery
- pharma development
- pharmaceutical discovery
Websites similar to drugdiscoverynews.com
-
discoverymedicine.com
-
Global rank
282.9K
-
Daily Visitors
534
-
-
ddn-news.com
-
Global rank
907.4K
-
Daily Visitors
N/A
-
-
bioseeker.com
-
Global rank
117.1K
-
Daily Visitors
N/A
-
-
pharmiweb.com
-
Global rank
57.5K
-
Daily Visitors
6.6K
-
-
pharmiweb.co.uk
-
Global rank
N/A
-
Daily Visitors
N/A
-